Trial intelligence / Profile preview

Tolvaptan and Renal Sodium Handling in Healthy Volunteers

NCT03910231Phase 1Completed

Sponsor
Brigham and Women's Hospital
Start
Feb 2012
Primary completion
Sep 2014
01

Overview

Phase 1, randomised, triple-blind trial of tolvaptan in hypertension (HTN), sponsored by Brigham and Women's Hospital. Started Feb 2012; status: completed.

02

Drugs

tolvaptan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT03910231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03910231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call